AceLink Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $35M

  • Investors
  • 7

AceLink General Information

Description

Operator of a biopharmaceutical company intended to focus on developing drugs for genetically associated human diseases. The company focuses on developing novel therapeutics for genetically associated kidney disorders, such as autosomal dominant polycystic kidney disease, autosomal recessive polycystic kidney disease and Fabry disease, enabling medical practitioners to offer safe and effective medicines to address diseases.

Contact Information

Website
www.acelinktherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 39600 Eureka Drive
  • Suite 151
  • Newark, CA 94560
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 39600 Eureka Drive
  • Suite 151
  • Newark, CA 94560
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AceLink Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 16-Sep-2023 $35M Completed Clinical Trials - Phase 2
2. Early Stage VC 10-May-2021 Completed Clinical Trials - Phase 1
1. Seed Round 28-Jul-2019 $4M $4M Completed Pre-Clinical Trials
To view AceLink’s complete valuation and funding history, request access »

AceLink Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view AceLink’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

AceLink Patents

  • 10

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

AceLink Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024251986-A1 Novel compounds and uses thereof Pending 03-Apr-2023
EP-4688779-A2 Novel compounds and uses thereof Pending 03-Apr-2023
US-20260234163-A1 Novel compounds and uses thereof Pending 03-Apr-2023
WO-2024211244-A2 Novel compounds and uses thereof Inactive 03-Apr-2023
WO-2024211244-A3 Novel compounds and uses thereof Inactive 03-Apr-2023 C07D515/18
To view AceLink’s complete patent history, request access »

AceLink Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AceLink Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cenova Capital Venture Capital Minority
HSG (Hong Kong) Venture Capital Minority
Huabio Corporation Minority
Kaitai Capital Venture Capital Minority
Shengshan Asset Management Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

AceLink FAQs

  • When was AceLink founded?

    AceLink was founded in 2018.

  • Where is AceLink headquartered?

    AceLink is headquartered in Newark, CA.

  • What is the size of AceLink?

    AceLink has 9 total employees.

  • What industry is AceLink in?

    AceLink’s primary industry is Drug Discovery.

  • Is AceLink a private or public company?

    AceLink is a Private company.

  • What is AceLink’s current revenue?

    The current revenue for AceLink is .

  • How much funding has AceLink raised over time?

    AceLink has raised $63.8M.

  • Who are AceLink’s investors?

    Cenova Capital, HSG (Hong Kong), Huabio, Kaitai Capital, and Shengshan Asset Management are 5 of 7 investors who have invested in AceLink.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process